P110002S032

None

FDA Premarket Approval P110002 S032

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP110002S032
Classification NameNone
Applicant
PMAP110002
SupplementS032

Supplemental Filings

Supplement NumberDateSupplement Type
P110002Original Filing
S031 2021-10-05 30-day Notice
S030 2021-04-08 30-day Notice
S029 2021-01-19 30-day Notice
S028
S027
S026 2020-11-23 30-day Notice
S025
S024 2020-03-17 30-day Notice
S023 2020-01-21 30-day Notice
S022 2019-09-04 Normal 180 Day Track No User Fee
S021 2018-04-17 30-day Notice
S020 2018-01-05 Normal 180 Day Track No User Fee
S019 2017-05-05 30-day Notice
S018 2017-04-26 30-day Notice
S017
S016 2016-11-01 Normal 180 Day Track No User Fee
S015 2016-09-30 Normal 180 Day Track No User Fee
S014
S013 2015-12-31 30-day Notice
S012 2015-06-05 Special (immediate Track)
S011 2015-04-20 Normal 180 Day Track
S010 2015-04-06 Normal 180 Day Track No User Fee
S009 2014-12-08 Real-time Process
S008 2014-12-08 30-day Notice
S007 2014-06-27 30-day Notice
S006 2014-04-04 30-day Notice
S005 2014-03-28 Normal 180 Day Track No User Fee
S004 2014-01-24 30-day Notice
S003 2013-11-18 30-day Notice
S002 2013-09-12 Normal 180 Day Track No User Fee
S001 2013-09-12 Normal 180 Day Track No User Fee

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.